Adams Respiratory Therapeutics acquires Cornerstone BioPharma Inc- from Cornerstone BioPharma Hldg


US - Adams Respiratory Therapeutics (ART) acquired the Humibid(TM) brands of Cornerstone BioPharma Inc, a manufacturer of prescription pharmaceuticals intended for final consumption, in exchange for AlleRx(TM) brands of ART.

Deal Information

Credit & Investment Research

Market Research

News